Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

1:25 PM - 1:35 PM PT

316 - High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab +/- Docetaxel in Previously-Irradiated HNSCC
Speaker: Vera, Alberto, MD - UPMC Cancer Center, Pittsburgh, PA
1:25 PM - 1:35 PM PT

321 - Low-Dose Radiotherapy Modulates Dendritic Cell Metabolism to Reprogram the Tumor Immune Microenvironment
Speaker: Zhou, Yuntao - Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin
1:25 PM - 1:35 PM PT

326 - Plan Quality Reporting of the Phase II Stereotactic MR-Guided Adaptive Radiation Therapy in One Fraction (SMART ONE) Trial
Speaker: Mittauer, Kathryn, PhD - Miami Cancer Institute- Baptist Health South Florida, Miami, FL
1:35 PM - 1:45 PM PT

305 - Temporal Effects of Dose and Fractionation of FLASH and Conventional Irradiation on Hippocampal Neurogenesis and Mechanisms of FLASH-Induced Neuroprotection
Speaker: Katila, Nikita, PhD - Stanford School of Medicine, Stanford, CA
1:35 PM - 1:45 PM PT

311 - Sulfur Colloid SPECT/CT Tracking for Evaluation of Liver Function: Longitudinal Assessment During Radiation Therapy (STELLAR) Prospective Study - Toward Imaging Biomarker-Guided Radiotherapy
Speaker: Apisarnthanarax, Smith, MD - University of Washington Radiation Oncology, Seattle, WA
1:35 PM - 1:45 PM PT

327 - Simplified Imaging-Based Dosimetry of Organs and Inherently Heterogeneous Tumors for <sup>131</sup>I-MIBG Therapy Using Combined Pretherapy <sup>123</sup>I-MIBG and Posttherapy <sup>131</sup>I-MIBG SPECT Imaging
Speaker: Wang, Yiran - University of California, San Francisco, San Francisco, CA
1:35 PM - 1:45 PM PT

Discussant
Speaker: Mell, Loren, MD, FASTRO - University of California, San Diego, La Jolla, CA
1:35 PM - 1:45 PM PT

Discussant
Speaker: Shiao, Stephen, MD, PhD - Cedars-Sinai Medical Center, Los Angeles, CA
1:45 PM - 1:55 PM PT

328 - A Multicenter, Blinded, Intensity Modulated Proton Therapy Competitive Planning Study for Head and Neck Cancers: The Urgency for Guidelines and Standards
Speaker: Snider, James, MD - Proton International, Tampa, FL
1:45 PM - 1:55 PM PT

Discussant
Speaker: Henke, Lauren, MD, MS - University Hospitals/Case Western Reserve University, Cleveland, Ohio
1:45 PM - 1:55 PM PT

Discussant
Speaker: Breen, William, MD - Mayo Clinic Rochester, Rochester, Minnesota
2:30 PM - 2:40 PM PT

329 - Phase II Trial of 'Re-Priming' Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Speaker: Kumar, Kiran, MD, MBA - UT Southwestern Medical Center, Dallas, TX